Leading Innovation in Psychiatric Treatment | Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company redefining psychiatry by leveraging deep neurobiological insights to develop personalized medicines for neuropsychiatric conditions. Using a precision psychiatry platform built on 15 years of neurobiology research, the company targets core brain processes in patients with major depressive disorder, bipolar depression, and schizophrenia.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2026
Nov 2023
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
